| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 01/21/2010 | WO2010007756A1 Pyridine derivative having ttk inhibition activity |
| 01/21/2010 | WO2010007593A1 Methods of long-term culture of eukaryotic cells and uses thereof |
| 01/21/2010 | WO2010007353A1 Catabolic agents |
| 01/21/2010 | WO2010007034A1 Use of pyrimidylaminobenzamide derivatives for the treatment of fibrosis |
| 01/21/2010 | WO2009146153A3 Manufacture, transport and delivery of material containing highly polarized nuclei |
| 01/21/2010 | WO2009121600A3 Hydroxytyrosol formulations for the treatment and prevention of dna oxidative damages in post-menopausal conditions |
| 01/21/2010 | WO2009061447A3 Use of umbilical cord blood in the treatment of premature birth complications |
| 01/21/2010 | US20100016448 Flashmelt oral dosage formulation |
| 01/21/2010 | US20100016391 Isoxazoline Compounds Having MIF Antagonist Activity |
| 01/21/2010 | US20100016380 TNF-alpha production inhibitors |
| 01/21/2010 | US20100016324 Pharmaceutical compositions for the treatment of cellulite |
| 01/21/2010 | US20100016323 2-phenyl substituted imidazotriazinones as phosphodiesterase inhibitors |
| 01/21/2010 | US20100016259 Malonyl-CoA Decarboxylase Inhibitors Useful as Metabolic Modulators |
| 01/21/2010 | US20100016255 Method of treating vitamin b12 deficiency |
| 01/21/2010 | US20100016221 Method of degrading protein by chaperone-mediated autophagy |
| 01/21/2010 | US20100016216 Adiponectin and uses thereof |
| 01/21/2010 | US20100015221 Orally rapid disintegrating tablet preparation comprising fat-soluble active ingredients |
| 01/21/2010 | US20100015218 Compositions and methods for potentiated activity of biologically active molecules |
| 01/21/2010 | US20100015160 Compositions and methods for diagnosing and treating endometriosis |
| 01/21/2010 | US20100015149 Combination of epothilone analogs and chemotherapeutic agents for the treatment of proliferative diseases |
| 01/21/2010 | US20100015147 Methods for increasing analgesic potency and attenuating adverse excitatory effects of bimodally-acting opioid agonists by inhibiting GM1-ganglioside |
| 01/21/2010 | DE10004815B4 Menschliche intestinale Natriumphosphat-Kotransporter Human intestinal sodium phosphate cotransporter |
| 01/21/2010 | CA2730793A1 Azole compound |
| 01/21/2010 | CA2730281A1 Novel indole derivative having, carbamoyl group, ureido group and substituted oxy group |
| 01/21/2010 | CA2730225A1 Use of pyrimidylaminobenzamide derivatives for the treatment of fibrosis |
| 01/21/2010 | CA2728095A1 Pyrazole-containing tricyclic compounds as antagonists of an ep1 receptor |
| 01/20/2010 | EP2145897A2 Therapeutic methods and compositions based on serrate proteins and nucleic acids |
| 01/20/2010 | EP2145883A1 Dibenzyl lipoic acid derivatives and their use in treatment of disease |
| 01/20/2010 | EP2145879A1 Pyrazine derivatives, methods of use, and methods for preparing same |
| 01/20/2010 | EP2145623A1 Pharmaceutical and cosmetic compositions for accelerated healing of wounds and other surface damages |
| 01/20/2010 | EP2003140B1 Galactose derivative, drug carrier and medicinal composition |
| 01/20/2010 | EP1827415B1 Cyclopropane acid derivatives for the reduction of lipid levels |
| 01/20/2010 | EP1513818B1 Heterocyclic inhibitors of vegfr-2 kinases |
| 01/20/2010 | EP1506214B1 6-11 bicyclic ketolide derivatives |
| 01/20/2010 | EP1458679B1 Pyrrolidine derivatives as prostaglandin modulators |
| 01/20/2010 | EP1456160B1 Vitamin d analogues |
| 01/20/2010 | EP1443970B1 Promoters exhibiting endothelial cell specificity and methods of using same |
| 01/20/2010 | EP1379272B1 Monoclonal antibodies directed against molecular mimetics of meningococcal b epitopes |
| 01/20/2010 | EP1202961B1 Arylsulfonamido-substituted hydroxamic acid derivatives |
| 01/20/2010 | EP1117419B1 Contortrostatin (cn) and methods for its use in preventing metastasis and other conditions |
| 01/20/2010 | EP0971724B1 Expression of active human factor ix in mammary tissue of transgenic animals |
| 01/20/2010 | CN101627991A Endurance improving agent |
| 01/20/2010 | CN100582097C Broadspectrum substituted benzisoxazole sulfonamide HIV protease inhibitors |
| 01/20/2010 | CN100582087C 2-aminobicyclo 3.1.0 hexane-2,6-dicarboxylic ester derivative |
| 01/20/2010 | CN100582084C Hydrophobic polyamine analogs and methods for their use |
| 01/20/2010 | CN100581551C Utilization of phosphatidylserine in the treatment of attention deficit syndrome (ADHS) |
| 01/19/2010 | USRE41084 Rapamycin 42-ester with 3-hydroxy-2-(hydroxymethyl)-2-methyl propionic acid (CCI-779) and 4-dimethylamino-but-2-enoic acid(4-(3-chloro-4-fluoro-phenylamino)-3-cyano-7-ethoxy-quinol in-6-yl)amide (EKB-569); synergistic; antitumor agents |
| 01/19/2010 | US7649097 Tetracyclic arylsulfonyl indoles having serotonin receptor affinity useful as therapeutic agents, process for their preparation and pharmaceutical compositions containing them |
| 01/19/2010 | US7649095 Piperidine derivatives and agent comprising the derivative as active ingredient |
| 01/19/2010 | US7649085 Saquinavir conjugates and antibodies useful in immunoassay |
| 01/19/2010 | US7649015 Saquinavir-like, a Lopinavir-like, a Ritonavir-like, a Indinavir-lik, a atazanavir-like, Nelfinavir-like.a Tipranavir-like, a Amprenavir-like, a KNI-like. a cyclic carbonyl-like phosphonate HIV protease inhibitors; drug designing |
| 01/19/2010 | US7649012 Compounds, pharmaceutical compositions containing same, and methods of use for same |
| 01/19/2010 | US7649008 Crystal of 4-(1-((4-methylbenzothiophen-3-yl)methyl)benzimidazol-2-ylthio)butanoic acid; has chymase inhibitory activity in living body and can be used as a preventive and/or remedy for inflammatory diseases, allergic diseases, respiratory tract diseases, circulatory diseases, or bone metabolic diseases |
| 01/19/2010 | US7649001 Fused benzene derivative and use |
| 01/19/2010 | US7649000 (2'S,2''R)-4-(2'-(2''-amino-3''-(4'''-ethoxyphenyl)propanoylamino)-3'-phenylpropanoyl-amino)piperidine- 1-carboxamidine; inflammatory bowel disease, arthritis, inflammation, septic shock, hypotension, cancer, adult respiratory distress syndrome, disseminated intravascular coagulation |
| 01/19/2010 | US7648999 Activator for peroxisome proliferator-activated receptor δ |
| 01/19/2010 | US7648986 Hypertension, atherosclerosis, restenosis, cerebral ischemia, cerebral vasospasm, or erectile dysfunction; 2-(5-chloro-2-thienyl)-N-(1H-indazol-5-yl)thieno[3,2-d]pyrimidin-4-amine |
| 01/19/2010 | US7648971 Thrombopoietin mimetics |
| 01/19/2010 | US7648959 Methods and compositions for the treatment of diseases of the eye |
| 01/19/2010 | US7648695 A halogenated xanthene derivative, preferably Rose Bengal; can be delivered at high concentrations to certain tissues |
| 01/19/2010 | CA2439268C Combination comprising a signal transduction inhibitor and an epothilone derivative |
| 01/19/2010 | CA2427660C Biphenylcarboxamides useful as lipid lowering agents |
| 01/19/2010 | CA2393466C Hydantoin derivative compounds, pharmaceutical compositions, and methods of using same |
| 01/19/2010 | CA2373093C Methods and compounds for inhibiting amyloid deposits |
| 01/19/2010 | CA2368097C Amide derivatives of 3,4-dihydroquinazolinone compounds useful as cytokine inhibitors |
| 01/19/2010 | CA2366911C Compositions for improving fertility |
| 01/19/2010 | CA2335107C Leptin-mediated gene-induction |
| 01/19/2010 | CA2315897C Novel camptothecin tetracyclic analogues, preparation, methods, applications as medicines and pharmaceutical compositions containing them |
| 01/19/2010 | CA2239904C Inhibitors of interleukin-1.beta. converting enzyme |
| 01/14/2010 | WO2010005958A2 1,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenase |
| 01/14/2010 | WO2010005851A1 Combination therapy for treating iron disorders |
| 01/14/2010 | WO2010005047A1 Intestinal environment-improving agent |
| 01/14/2010 | WO2010005004A1 Xanthine oxidase inhibitor and uric acid production inhibitor |
| 01/14/2010 | WO2010004982A1 Ameliorating or therapeutic agent for dyslipidemia |
| 01/14/2010 | WO2010004816A1 Inhibitor of degranulation of mast cell |
| 01/14/2010 | WO2010004761A1 Stat3 inhibitor containing quinolinecarboxamide derivative as active ingredient |
| 01/14/2010 | WO2010004339A1 Processes for the preparation of crystalline forms of sunitinib malate |
| 01/14/2010 | WO2010004054A2 Construction of cell penetrating nucleic acids |
| 01/14/2010 | WO2010003803A1 Nutritional composition containing oligosaccharide mixture |
| 01/14/2010 | WO2010003287A1 THE USE OF POTASSIUM 2-(α- HYDROXYPENTYL) BENZOATE IN THE MANUFACTURE OF MEDICAMENTS FOR PREVENTING AND/OR TREATING SENILE DEMENTIA |
| 01/14/2010 | WO2009080821A3 Multitarget compounds active at a ppar and cannabinoid receptor |
| 01/14/2010 | US20100011453 Model for muscular dystrophy and cardiomyopathy |
| 01/14/2010 | US20100011451 Phenotypic and genotypic differences of mva strains |
| 01/14/2010 | US20100010207 Rna interference mediating small rna molecules |
| 01/14/2010 | US20100010200 for Systemic Inflammatory Response Syndrome (SIRS), including severe sepsis, septic shock and sepsis related to cardiac dysfunction |
| 01/14/2010 | US20100010195 Novel tumor necrosis factor receptor homolog and nucleic acids encoding the same |
| 01/14/2010 | US20100010092 Use of modafinil to treat restless leg syndrome |
| 01/14/2010 | US20100010069 Extended Length Borane Phosphonate Nucleic Acid Compounds |
| 01/14/2010 | US20100010036 Drugs for the treatment of sarcoglycanopathies |
| 01/14/2010 | US20100010020 Phosphodiesterase 4 inhibitors |
| 01/14/2010 | US20100010004 Inhibitors of histone deacetylase |
| 01/14/2010 | US20100009988 Piperazinyl-, piperidinyl- and morpholinyl-derivatives as novel inhibitors of histone deacetylase |
| 01/14/2010 | US20100009976 Benzothiazin-3-one compound and intermediate therefor |
| 01/14/2010 | US20100009966 Substituted lactams as inhibitors of abeta protein production |
| 01/14/2010 | US20100009965 Cyclic malonamides as inhibitors of abeta protein production |
| 01/14/2010 | US20100009939 Concurrent drugs |
| 01/14/2010 | US20100009914 Method of protecting sensitive molecules from a photo-polymerizing environment |
| 01/14/2010 | US20100009896 Capture agents and related compositions, methods and systems |
| 01/14/2010 | US20100009439 ANTI-IGF-I RECEPTOR ANTIBODIES, DNAs, VECTORS, HOST CELLS AND GENETIC CONSTRUCTS |
| 01/14/2010 | US20100009001 Novel nanoparticles |